… used tissue-based proteomic profiling analysis in patients with endometrial cancer and
hyperplasia, and control patients. … Thirty-six patients (twelve with endometrial cancer, twelve with …

… This study aimed to identify and validate proteomics-based biomarkers useful for … hyperplasia
(BPH). Global protein expression patterns in fresh tissue specimens from 8 patients with …

… proteome profiling.24 The intensity of different peptides from the same protein can vary
greatly, impacting the accuracy of the protein abundance measurement. Moreover, the sensitivity …

… from benign prostate hyperplasia (BPH, n = 11) and prostate cancer (PCA, n = 12) patients by
two… 2-DE results revealed 88 protein spots expressed differentially among hyperplasia and …

… This study explored the proteomic profiles of plasma samples obtained from EC patients,
those with hyperplasia (Hy), and a control group (CO). A combination of techniques, such as 2D…

… In the present study, we have profiled the sera of patients with PCa and benign prostatic
hyperplasia (BPH) using the gel- and lectin-based proteomics methods and demonstrated the …

… In the current study, proteomics analyses were utilized to identify proteins altered in the BPH
stromal compartment from patients with symptomatic BPH. Stromal cells were isolated from …

… model able to discriminate between PCa and BPH patients based on a combination of
clinical and proteomic variables. Proteomic data were generated by a multistage biomarker …

… the serum proteome of dogs with BPH. This study aimed to compare serum proteome profiles
of … This research represents the first investigation into serum proteome profiling in dogs with …

… prostate hyperplasia (BPH) patients. Patients and Methods: Liquid chromatography-mass
spectrometry-based proteomic analysis was performed in PPAT-conditioned media (CM) from …